Bilateral Breast Tomosynthesis denials in California external review

In the California DMHC record, independent physician reviewers decided 18 published external-review cases involving Bilateral Breast Tomosynthesisand overturned the plan’s denial in 88.9%. That is a historical result among cases that reached this program, not a forecast for an individual appeal.

California DMHC decisions
18
2015–2017
Overturned
88.9%
16 denials reversed
Typical time to a decision
14 days
Most land between 10 and 20 days

What the reviewers wrote

Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.

Where the denial was overturned

Nature of Statutory Criteria/Case Summary: An enrollee has requested reimbursement for bilateral breast tomosynthesis for evaluation of the enrollee, who was asymptomatic. Findings: The 3 physician reviewers found that breast tomosynthesis is a technique that was developed several years ago as a problem solving adjunct to routine mammography. Applying the same basic concept as computed tomography (CT) scanning, the logic is that by separating the various layers of breast tissue, one can better detect abnormalities. This has been shown to be most useful in the evaluation of dense breasts. In this patient’s case, her breast tissue was heterogeneously dense. It is specifically those patients who have dense breasts that can benefit most from breast tomosynthesis. The ability to separate out the overlapping structures enables the possibility of demonstrating an otherwise occult tumor.
Experimental/Investigational · 2017 · IMR EI17-24405
Nature of Statutory Criteria/Case Summary. An enrollee has requested bilateral breast tomosynthesis for the enrollee’s breast cancer screening. Findings: Three physician reviewers found that the patient has a family history of breast cancer. The patient underwent a routine screening mammogram consisting of a combination two dimensional (2D) and three dimensional (3D) tomosynthesis examination. The report noted that this study was the patient’s baseline mammogram, and no prior mammograms were available for comparison. There were no masses, areas of suspicious calcifications, or areas of architectural distortion. The patient’s breasts were described as being heterogeneously dense. The Health Plan has denied reimbursement for bilateral breast tomosynthesis. Per the Health Plan, the service at issue was investigational for the evaluation of this patient.
Experimental/Investigational · 2016 · IMR EI16-23502

Where the denial was upheld

Worth reading too — these show what an appeal has to overcome.
Nature of Statutory Criteria/Case Summary: An enrollee has requested reimbursement for the bilateral breast tomosynthesis performed. Findings: The physician reviewer found that the patient who is asymptomatic with respect to her breasts. On date of dispute, she underwent a routine screening mammogram consisting of a three-dimensional tomosynthesis study with synthetically reconstructed two-dimensional views. The current images were compared to prior mammograms and no interval changes were noted. There were no masses, areas of suspicious calcifications, or areas of architectural distortion. Her breasts were described as average in density. The patient has requested reimbursement for the bilateral breast tomosynthesis performed on date of dispute. The Health Plan has denied this request as investigational.
Experimental/Investigational · 2017 · IMR EI17-24611
Nature of Statutory Criteria/Case Summary: An enrollee has requested bilateral breast tomosynthesis for evaluation of her medical condition. Two physician reviewers found that in this patient’s case, the services at issue were not likely to have been more effective than other alternatives. There is a lack of support for the bilateral breast tomosynthesis in this clinical setting. The medical records do not indicate an increased risk of breast cancer. Although breast tomosynthesis is a promising technique, the superior efficacy of bilateral breast tomosynthesis has not been established. Final Result: Two reviewers determined that the services at issue were not likely to be more beneficial for evaluation of the patient’s medical condition than any available standard therapy. Therefore, the Health Plan’s denial should be upheld.
Experimental/Investigational · 2015 · IMR EI15-20375

Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California external-review outcomes. Other state and federal programs have different eligibility rules, processes, and current availability; the rates here do not transfer to those programs or predict an individual result. Excerpts are quoted verbatim from the public record and describe this treatment generally, not any individual case.

How to use this in your appeal

These outcomes describe eligible cases completed through California DMHC’s Independent Medical Review program. They do not estimate the chance that an internal appeal, an external review in another jurisdiction, or your individual case will succeed. Use the record to identify evidence patterns involving Bilateral Breast Tomosynthesis, then check the rights and deadlines that apply to your plan.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · AGGREGATES + DEIDENTIFIED DECISION EXCERPTS/REFERENCE IDS · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Denied Bilateral Breast Tomosynthesis? Use the California record to prepare.

Explain my denial — freeStart my appeal · $39